Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Saudi Medicine|December 14, 2020
Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infectionKadir Canoglu, Bengu Saylan
Medeniyet Medical Journal|April 8, 2021
The Comparison Between Non-High Risk Patients with and Without Cancer Diagnosed with Pulmonary EmbolismTayfun Caliskan, Ozlem Turkoglu, Kadir Canoglu, et al.
Southern African Journal of Infectious Diseases|September 6, 2021
Retrospective analysis of severe COVID-19 pneumonia patients treated with lopinavir/ritonavir: A comparison with survivor and non-survivor patientsOmer Ayten, Bengu Saylan
Revista Da Associacao Medica Brasileira (1992)|December 17, 2020
Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational studyTayfun Caliskan, Bengu Saylan
Annals of Saudi Medicine|October 7, 2021
Patients with hypertension hospitalized with COVID-19 pneumonia using angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers or other antihypertensives: retrospective analysis of 435 patientsSeyma Baslilar, Bengu Saylan
Mediterranean Journal of Hematology and Infectious Diseases|January 20, 2023
Management of Latent Tuberculosis Infection Based on T-SPOT.TB Assay in Patients with Hematological MalignanciesEmrah Kilicaslan, Kadir Canoglu
Tobacco Induced Diseases|June 28, 2021
Comparative assessment of outcomes of smoking cessation therapies and role of free medications in successful long-term abstinenceBengu Saylan, Seyma Baslilar, Zafer Kartaloglu
International Journal of Health Sciences|March 18, 2022
Risk factors for prolonged nucleic acid conversion time in patients with COVID-19Kadir Canoglu, Tayfun Caliskan, Ecem Sinmez
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|February 15, 2021
CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvementCesur Samanci, Bengu Saylan, Gokce Gulsen, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 18, 2025
The ACE/lymphocyte ratio and CONUT score: Key predictors of extrapulmonary involvement and recurrence in sarcoidosisKadir Canoglu, Omer Ayten, Gokce Kulah, et al.
Pageof 2